

02 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/02/3160415/0/en/Nacuity-Pharmaceuticals-Granted-U-S-FDA-Breakthrough-Therapy-Designation-for-NPI-001-N-acetylcysteine-amide-Tablets-for-the-Treatment-of-Retinitis-Pigmentosa.html